Trevi gets $50M and David Meeker as its new chairman; Spark in line for a PRV
→ Trevi Therapeutics in New Haven, CT has raised a $50.5 million C round. The biotech has been pushing a drug called Nalbuphine ER …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
